Global cancer observatory2022. Available from: https://gco.iarc.fr/.
Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. Journal of the National Cancer Center. 2022;available online.
Pahlavani N, Rostami D, Ebrahimi F, Azizi-Soleiman F. Nuts effects in chronic disease and relationship between walnuts and satiety: review on the available evidence. Obes Med. 2020;17:100173.
Article
Google Scholar
Shabgah AG, Norouzi F, Hedayati-Moghadam M, Soleimani D, Pahlavani N, Navashenaq JG. A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. Nutr Metab (Lond). 2021;18(1):22.
Article
Google Scholar
Hadi V, Pahlavani N, Malekahmadi M, Nattagh-Eshtivani E, Navashenaq JG, Hadi S, et al. Nigella sativa in controlling type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: molecular aspects. J Res Med Sci. 2021;26:20.
Article
Google Scholar
Nattagh-Eshtivani E, Barghchi H, Pahlavani N, Barati M, Amiri Y, Fadel A, et al. Biological and pharmacological effects and nutritional impact of phytosterols: a comprehensive review. Phytother Res. 2022;36(1):299–322.
Article
Google Scholar
Mansouri M, Pahlavani N, Sharifi F, Varmaghani M, Shokri A, Yaghubi H, et al. Dairy consumption in relation to Hypertension among a large Population of University students: the MEPHASOUS Study. Diabetes Metab Syndr Obes. 2020;13:1633–42.
Article
Google Scholar
Lin TY, Lan WH, Chiu YF, Feng CL, Chiu CH, Kuo CJ, et al. Statins’ regulation of the virulence factors of Helicobacter pylori and the production of ROS May inhibit the development of gastric Cancer. Antioxidants (Basel). 2021;10(8).
Kwon SY, Choi SH, Park YS, Park DY, Park YI, Hwang I, et al. Lipid MALDI MS profiles of gastric Cancer. Open Proteom J. 2014;7:1–4.
Article
Google Scholar
Tao L, Zhou J, Yuan C, Zhang L, Li D, Si D, et al. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Metabolomics. 2019;15(6):86.
Article
Google Scholar
Fang Z, He M, Song M. Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank. Br J Cancer. 2021;124(3):663–70.
Article
Google Scholar
Zhang D, He W, Wu C, Tan Y, He Y, Xu B, et al. Scoring system for Tumor-Infiltrating lymphocytes and its prognostic value for gastric Cancer. Front Immunol. 2019;10:71.
Article
Google Scholar
Xie S, Mo P, Li N, Cai W, Ruan J, Ye J, et al. Tumor-infiltrating lymphocyte-based risk score for Predicting Prognosis in Gastric Cancer. Front Oncol. 2020;10:522015.
Article
Google Scholar
Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375(6576):eabf9419.
Article
Google Scholar
Yamakoshi Y, Tanaka H, Sakimura C, Deguchi S, Mori T, Tamura T, et al. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer. Int J Oncol. 2020;57(1):171–82.
Google Scholar
Munoz-Erazo L, Rhodes JL, Marion VC, Kemp RA. Tertiary lymphoid structures in cancer - considerations for patient prognosis. Cell Mol Immunol. 2020;17(6):570–5.
Article
Google Scholar
Cheng N, Li P, Cheng H, Zhao X, Dong M, Zhang Y, et al. Prognostic Value of Tumor-Infiltrating lymphocytes and tertiary lymphoid structures in Epstein-Barr Virus-Associated and -negative gastric carcinoma. Front Immunol. 2021;12:692859.
Article
Google Scholar
Li Q, Zhang D, He W, Chen T, Yan Z, Gao X, et al. CD8(+) T cells located in tertiary lymphoid structures are associated with improved prognosis in patients with gastric cancer. Oncol Lett. 2020;20(3):2655–64.
Article
Google Scholar
Christofides A, Tijaro-Ovalle NM, Boussiotis VA. Commentary on: combination of metabolic intervention and T cell therapy enhances solid Tumor Immunotherapy. Immunometabolism. 2021;3(2).
Hao M, Hou S, Li W, Li K, Xue L, Hu Q, et al. Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy. Sci Transl Med. 2020;12(571).
Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, et al. Oxysterols direct B-cell migration through EBI2. Nature. 2011;475(7357):519–23.
Article
Google Scholar
Herbel C, Patsoukis N, Bardhan K, Seth P, Weaver JD, Boussiotis VA. Clinical significance of T cell metabolic reprogramming in cancer. Clin Transl Med. 2016;5(1):29.
Article
Google Scholar
Le Bourgeois T, Strauss L, Aksoylar HI, Daneshmandi S, Seth P, Patsoukis N, et al. Targeting T cell metabolism for improvement of Cancer Immunotherapy. Front Oncol. 2018;8:237.
Article
Google Scholar
Pih GY, Gong EJ, Choi JY, Kim MJ, Ahn JY, Choe J, et al. Associations of serum lipid level with gastric Cancer Risk, Pathology, and prognosis. Cancer Res Treat. 2021;53(2):445–56.
Article
Google Scholar
Tan MC, Graham DY. Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. Gastrointest Endosc. 2019;90(3):457–60.
Article
Google Scholar
Shen JG, Jin LD, Dong MJ, Wang LB, Zhao WH, Shen J. Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival. Transl Cancer Res. 2020;9(10):6206–13.
Article
Google Scholar
Zou Y, Wu L, Yang Y, Ding Z, Huang J, Li P, et al. Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: a multicenter retrospective study. Transl Oncol. 2021;14(1):100925.
Article
Google Scholar
Posch F, Silina K, Leibl S, Mundlein A, Moch H, Siebenhuner A, et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology. 2018;7(2):e1378844.
Article
Google Scholar
Hegde PS, Karanikas V, Evers S. The where, the when, and the How of Immune Monitoring for Cancer Immunotherapies in the era of checkpoint inhibition. Clin Cancer Res. 2016;22(8):1865–74.
Article
Google Scholar
Ma J, Li J, Qian M, Han W, Tian M, Li Z, et al. PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28 – 8 and E1L3N). Diagn Pathol. 2018;13(1):91.
Article
Google Scholar
Gars E, Butzmann A, Ohgami R, Balakrishna JP, O’Malley DP. The life and death of the germinal center. Ann Diagn Pathol. 2020;44:151421.
Article
Google Scholar
Guo G, Wang Y, Zhou Y, Quan Q, Zhang Y, Wang H, et al. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J Immunother Cancer. 2019;7(1):179.
Article
Google Scholar
Zamanian-Daryoush M, Lindner D, Tallant TC, Wang Z, Buffa J, Klipfell E, et al. The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J Biol Chem. 2013;288(29):21237–52.
Article
Google Scholar
Wilhelm AJ, Zabalawi M, Owen JS, Shah D, Grayson JM, Major AS, et al. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem. 2010;285(46):36158–69.
Article
Google Scholar
Mesin L, Ersching J, Victora GD. Germinal. Cent B Cell Dynamics Immun. 2016;45(3):471–82.
Google Scholar
Shi J, Hou S, Fang Q, Liu X, Liu X, Qi H. PD-1 controls follicular T helper cell positioning and function. Immunity. 2018;49(2):264–74. e4.
Article
Google Scholar
Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunol Rev. 2020;296(1):48–61.
Article
Google Scholar
Huang Y, Chen Z, Wang H, Ba X, Shen P, Lin W, et al. Follicular regulatory T cells: a novel target for immunotherapy? Clin Transl Immunology. 2020;9(2):e1106.
Article
Google Scholar
Wing JB, Tekguc M, Sakaguchi S. Control of Germinal Center responses by T-Follicular Regulatory cells. Front Immunol. 2018;9:1910.
Article
Google Scholar
Burger F, Miteva K, Baptista D, Roth A, Fraga-Silva RA, Martel C, et al. Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet. Cardiovasc Res. 2021;117(3):743–55.
Article
Google Scholar
Li F, Du H, Li S, Liu J. The Association between metabolic syndrome and gastric Cancer in chinese. Front Oncol. 2018;8:326.
Article
Google Scholar
Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard-Alvarez A, Grondin G, et al. Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity. Cell. 2019;177(7):1701-13 e16.
Article
Google Scholar
Perera Molligoda Arachchige AS. Human NK cells: from development to effector functions. Innate Immun. 2021;27(3):212–29.
Article
Google Scholar
Kim SJ, Lim J, Nam GE, Park HS. Correlation between serum lipid parameters and Interleukin-10 concentration in obese individuals. J Obes Metab Syndr. 2021;30(2):173–7.
Article
Google Scholar
Barcelos ALV, de Oliveira EA, Haute GV, Costa BP, Pedrazza L, Donadio MVF, et al. Association of IL-10 to coronary disease severity in patients with metabolic syndrome. Clin Chim Acta. 2019;495:394–8.
Article
Google Scholar
Santos DCD, Ribeiro IS, Lopes DPS, Pereira IS, Santos DP, Muniz IPR, et al. Gender-related differences in the modulation of anthropometric, biochemical, and immune markers by physical activity in hypertensive and diabetic individuals. An Acad Bras Cienc. 2021;93(suppl 4):e20201905.
Article
Google Scholar
Moraitis AG, Freeman LA, Shamburek RD, Wesley R, Wilson W, Grant CM, et al. Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency. J Clin Lipidol. 2015;9(1):81–90.
Article
Google Scholar
Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kuckelhaus J, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13(1):925.
Article
Google Scholar
Sawant DV, Yano H, Chikina M, Zhang Q, Liao M, Liu C, et al. Adaptive plasticity of IL-10(+) and IL-35(+) Treg cells cooperatively promotes tumor T cell exhaustion. Nat Immunol. 2019;20(6):724–35.
Article
Google Scholar
Chen S, Crabill GA, Pritchard TS, McMiller TL, Wei P, Pardoll DM, et al. Mechanisms regulating PD-L1 expression on tumor and immune cells. J Immunother Cancer. 2019;7(1):305.
Article
Google Scholar
Chuang Y, Hung ME, Cangelose BK, Leonard JN. Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli. Innate Immun. 2016;22(8):647–57.
Article
Google Scholar
Shin HJ, Roh CK, Son SY, Hoon H, Han SU. Prognostic value of hypocholesterolemia in patients with gastric cancer. Asian J Surg. 2021;44(1):72–9.
Article
Google Scholar
Tomiki Y, Suda S, Tanaka M, Okuzawa A, Matsuda M, Ishibiki Y, et al. Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. J Exp Clin Cancer Res. 2004;23(2):233–40.
Google Scholar
Muldoon MF, Marsland A, Flory JD, Rabin BS, Whiteside TL, Manuck SB. Immune system differences in men with hypo- or hypercholesterolemia. Clin Immunol Immunopathol. 1997;84(2):145–9.
Article
Google Scholar
Waelti ER, Glueck R, Hess MW. Modulation of concanavalin A-induced lymphocyte stimulation by human low-density lipoproteins. Eur J Immunol. 1981;11(10):846–8.
Article
Google Scholar
Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12(4):240–60.
Article
Google Scholar
Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol induces CD8(+) T cell exhaustion in the Tumor Microenvironment. Cell Metab. 2019;30(1):143–56. e5.
Article
Google Scholar